F8M

2-amino-7-[3-(dimethylamino)propyl]-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid

Created:	2018-03-15
Last modified:	2021-03-01

Find Related PDB Entry
1 entries where F8M is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	0
Bond Count	46
Aromatic Bond Count	12

2D diagram of F8M

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-amino-7-[3-(dimethylamino)propyl]-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid
Synonyms	7-[3-(dimethylamino)propyl] Analog of Amlexanox
Systematic Name (OpenEye OEToolkits)	2-azanyl-7-[3-(dimethylamino)propyl]-5-oxidanylidene-chromeno[2,3-b]pyridine-3-carboxylic acid
Formula	C₁₈ H₁₉ N₃ O₄
Molecular Weight	341.361
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CN(C)CCCc3ccc1c(C(c2c(O1)nc(c(c2)C(O)=O)N)=O)c3
SMILES	CACTVS	3.385	CN(C)CCCc1ccc2Oc3nc(N)c(cc3C(=O)c2c1)C(O)=O
SMILES	OpenEye OEToolkits	2.0.6	CN(C)CCCc1ccc2c(c1)C(=O)c3cc(c(nc3O2)N)C(=O)O
Canonical SMILES	CACTVS	3.385	CN(C)CCCc1ccc2Oc3nc(N)c(cc3C(=O)c2c1)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.6	CN(C)CCCc1ccc2c(c1)C(=O)c3cc(c(nc3O2)N)C(=O)O
InChI	InChI	1.03	InChI=1S/C18H19N3O4/c1-21(2)7-3-4-10-5-6-14-11(8-10)15(22)12-9-13(18(23)24)16(19)20-17(12)25-14/h5-6,8-9H,3-4,7H2,1-2H3,(H2,19,20)(H,23,24)
InChIKey	InChI	1.03	UFHZMIKXSGTKFX-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	130293154
ChEMBL	CHEMBL4287613

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.